Adil Shareef Mohammed

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomas”.

WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.13.536816

N/A

0DataRank · unranked

2 citations

Shashi Jain, Naomi Lomeli, Kaijun Di, Nitesh Kumar Nandwana, Adil Shareef Mohammed +7 more

Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models

Pharmacological Research(2025)10.1016/j.phrs.2025.107697

N/A

0DataRank · unranked

6 citations

Shashi Jain, Naomi Lomeli, Javier Lepe, Kaijun Di, Nitesh Kumar Nandwana +7 more